reply

Posted

print

favorite this post 3/26-3/28: 7th Drug Formulation, Solubility and Bioavailability (Boston) hide this posting unhide

200 Stuart Street

(google map)

venue: Revere Hotel Boston Common

When over 80% of APIs in development are poorly water-soluble, drug companies must rely increasingly on new formulation and delivery strategies to maximize bioavailability. ExL's 7th Drug Formulation, Solubility and Bioavailability conference helps you recognize the precise thresholds where an enabled formulation becomes necessary, as well as determine which method to use and how to predict and gauge its success. This event provides you with an unmatched focus on the latest technologies and team skills that you need to gather and interpret first-in-human results and accelerate time-to-market.

Top Five Reasons to Attend

1. Breakthroughs in oral biologics delivery
2. Deeper understanding of self-association to enhance formulation performance
3. Strategies to design, interpret and rank the performance of the next generation of predictive models
4. Skills for getting long-term stability answers in the shortest time possible
5. Latest insights on 3D printing applications for enabled formulations

**FULL-DAY SEMINAR ON ADVANCES IN DRUG DELIVERYFeaturing oral biologics, long-acting injectables, amorphous biologics, depot microparticles, targeted tissue delivery - and much more!

URLs:
Website: https://go.evvnt.com/174423-0
Brochure: https://go.evvnt.com/174423-1
Booking: https://go.evvnt.com/174423-2

Prices:
Conference Only - Early Bird Pricing - Register by February 9, 2018: USD 1795,
Conference + Seminar - Early Bird Pricing - Register by February 9, 2018: USD 2495,
Conference Only - Standard Pricing: USD 1995,
Conference + Seminar - Standard Pricing: USD 2695,
Conference Only - Onsite Pricing: USD 2195,
Conference + Seminar - Onsite Pricing: USD 2895

Speakers: Rossitza Alargova Director, Formulations, INFINITY PHARMACEUTICALS, Gail Dempsey EOC and Director, Manufacturing Technologies, PIEDMONT ANIMAL HEALTH, Rakesh Dixit Vice President, RandD, Global Head, Biologics Safety, MEDIMMUNE, Emilija Fredro-Kumbaradzi Manager, Biowaivers and Biocorrelations, APOTEX, Ruchi Gupta Scientist, MEDIMMUNE

Category: Conferences | Science, Health and Medicine | Pharmaceuticals | Drug Development

Time: 8:00 am to 5:00 pm
  • do NOT contact me with unsolicited services or offers

post id: 6405174538

posted:

best of [?]